Journal of Histochemistry and Cytochemistry, Vol. 48, 643-652, May 2000, Copyright © 2000, The Histochemical Society, Inc.


ARTICLE

Tracking Micrometastasis to Multiple Organs with lacZ-tagged CWR22R Prostate Carcinoma Cells

Julianne L. Hollerana, Carson J. Millera, and Lloyd A. Culpa
a Department of Molecular Biology and Microbiology, Case Western Reserve University, School of Medicine, Cleveland, Ohio

Correspondence to: Lloyd A. Culp, Dept. of Molecular Biology and Microbiology, Case Western Reserve U., School of Medicine, Cleveland, OH 44106.


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Metastasis to organs other than lung is rarely observed in animal model systems of human prostate carcinoma (PCA), with the exception of already metastatic isolates of human PCA cultured for long periods of time. To analyze more directly the evolution of metastatic variants from primary PCA tumor isolates, the lacZ histochemical marker gene was transfected into the CWR22Rv1 cell line isolated from the CWR22R xenograft (primary tumor). Three clones of varying lacZ-expression stability were analyzed for tumorigenicity and progression in athymic nude mice. Clones B and D were highly tumorigenic in the subcutis; however, lacZ expression was highly unstable. In contrast, clone H demonstrated highly stable lacZ expression for >25 passages in culture or in animals. Clone H, injected sc in a PBS vehicle, gave a 15–40% tumorigenic take. All primary tumor-bearing animals exhibited micrometastases in lung and other organs. Clone H injected in a Matrigel vehicle gave 100% tumorigenicity, with all animals displaying micrometastases in lung, liver, and/or bone (lower frequency in brain and kidney). Overall, the relative frequency of micrometastasis to multiple organs was lung>liver=bone>>brain>kidney. Overt metastases were never observed in the lung or bone but were occasionally found in liver. lacZ-transfected clone H CWR22Rv1 cells represent a much more accurate model of metastasis of PCA to the organs normally involved in progression of the human disease. Use of marker gene-tagged cells and other high-resolution molecular techniques will now permit analyses of the earliest events in PCA progression and micrometastasis. (J Histochem Cytochem 48:643–651, 2000)

Key Words: histochemical marker gene, prostate carcinoma, micrometastasis, target organs


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Studies of human prostate carcinoma (PCA) in animal model systems have been hampered by the paucity of human PCA cells available in tissue culture (Pretlow et al. 1994 ; Lalani et al. 1997 ). Most studies of progression and metastasis have relied on already metastatic human PCA isolates from various target organs that have been cultured for long periods of time, e.g., DU145, PC3, and LNCaP (Pretlow et al. 1994 ; Zhau et al. 1996 ; Lalani et al. 1997 ; Rubio et al. 1998 ; Yang et al. 1999 ). Human PCA primary tumors, isolated from patients and carried in athymic nude or SCID mice as xenografts (Pretlow et al. 1994 ; van Weerden et al. 1996 ), offer the opportunity to isolate PCA primary tumor cell lines that would be valuable for analyzing progression of this disease. More effective molecular and cellular analyses of progression mechanisms require isolates of such primary tumors of human PCA (Pretlow et al. 1994 ).

The xenograft approach for isolating human PCA tissue and its passage in nude mice offers an intermediate stage in the development of new cell systems (van Steenbrugge et al. 1994 ; van Weerden et al. 1996 ). The Pretlows and their colleagues have made significant advances in isolation and characterization of many independent isolates of PCA primary tumors from patients. These are maintained as xenografts in athymic nude mice ( Pretlow et al. 1993 ; Wainstein et al. 1994 ; Cheng et al. 1996 ). This includes the CWR22 xenograft that was not metastatic in nude mice ( Wainstein et al. 1994 ). They reported subsequent isolation of a "relapsed" variant of this xenograft (CWR22R), which was androgen-independent and metastatic to lungs of nude mice ( Nagabhushan et al. 1996 ). A subline of the CWR22R xenograft (Pretlow xenograft #2152; Nagabhushan et al. 1996 ) was used by Jacobberger and colleagues to isolate and characterize a tissue-cultured cell line, CWR22Rv1 (Sramkoski et al. 1999 ). These cells display a karyotype similar to that of the original CWR22 xenograft (approximately 50 chromosomes), secrete prostate-specific antigen (PSA), display a specific point mutation in one exon of the androgen receptor gene (Tan et al. 1997 ), and generate primary tumors in the subcutis of nude mice pathologically characteristic of prostate carcinomas (Sramkoski et al. 1999 ).

CWR22Rv1 cells therefore offer an excellent opportunity to test possible metastatic spread to multiple organs from a cell population originally isolated from a human primary tumor and not from already metastatic subpopulations. If metastasis is observed with these cells to organs that are normally involved in the human disease, then we have a more relevant model system for evaluating mechanisms for PCA progression and metastasis.

Our laboratory has maximized sensitivity of progression and metastasis studies in animal models of tumor systems by transfecting a histochemical marker gene (e.g., bacterial lacZ or human placental alkaline phosphatase gene) into tumor cells, isolating relatively stable-expressing lacZ or PAP transfectants and testing for micrometastases in many target organs of athymic nude mice using ultrasensitive histochemical staining (Lin et al. 1990a , Lin et al. 1990b ; Kleinman et al. 1994 ). Use of histochemical markers permits ready visualization of both tagged tumor cells and neighboring host organ cells in the same field of vision. This is not possible with the use of fluorescent tags for tumor cells, such as luciferase or green-fluorescent protein (Rubio et al. 1998 ; Yang et al. 1999 ). These approaches with histochemical marker genes have been previously reviewed by us ( Lin and Culp 1992 ; Culp et al. 1998a , Culp et al. 1998b ) and others ( Kruger et al. 1999 ). They demonstrate our ability to detect single tumor cells in the vasculature and in target organs leading to micrometastases (Lin and Culp 1992 ; Lin et al. 1992 ; Culp et al. 1998a , Culp et al. 1998b ). They also enable us to evaluate relationships between neighboring tumor cells and host connective tissue cells at the highest resolution (Chang and Chung 1989 ; Culp et al. 1998a , Culp et al. 1998b ).

In the analyses reported here, the lacZ gene was transfected into cultured CWR22Rv1 cells, three clones were isolated, and the tumorigenic progression and metastasis of these clones were evaluated. These analyses identify one transfectant clone, referred to as LZ-CWR22R-H, that closely mimics metastatic progression normally observed in the human disease to lung, liver, and bone with a reasonable frequency. They also demonstrate remarkable stability of micrometastases in the lung and bone, as well as overt metastasis in the livers of this experimental animal system.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Isolation of lacZ-transfected CWR22R Cells
Early-passage CWR22Rv1 cells (Sramkoski et al. 1999 ), free of Mycoplasma, were obtained from Dr. James Jacobberger of this institution. This cell line (Sramkoski et al. 1999 ) was generated on an irradiated bed of STO mouse fibroblasts from the #2152 xenograft subline of CWR22R carried in nude mice by Dr. Thomas Pretlow and colleagues (Nagabhushan et al. 1996 ). Cells were grown in RPMI 1640 medium supplemented with 10% FCS and with penicillin and streptomycin. The bacterial lacZ gene, under regulation of the Rous sarcoma virus LTR on a bacterial plasmid carrying the neo R gene used for G418 selection (400 µg/ml), was transfected into CWR22R cells. Three clones (B, D, and H) were isolated as described previously (Lin et al. 1990a , Lin et al. 1990b ; Kleinman et al. 1994 ). These will be referred to as LZ-CWR22R-B, -D, or -H cells, respectively. The stability of lacZ expression during long-term culturing of these three clones, with or without selection drug, has been described previously (Culp et al. 1998a ). Briefly, Clone D is highly unstable in the absence of selection drug, with most cells losing X-gal stainability within 7–10 passages; Clone B displays intermediate stability; and Clone H is highly stable for lacZ expression for >25 passages, even in the absence of selection drug.

Tumorigenicity Studies
Athymic nude mice (HSD nu/nu) were bred and housed in the Athymic Animal Facility of the CWRU/Ireland Cancer Center under AAALAC-I approval. All procedures were executed under supervision of the Animal Care and Use Committee of Case Western Reserve University. Nude mice (4–6-week-old males) received two sets of India ink tattoos on each side of their hind flanks, between which cells were injected into the subcutis (Kleinman et al. 1994 ). The indicated number of lacZ-transfected CWR22R cells, dispersed from cultures by trypsinization, were then injected SC and animals monitored daily for evolution of primary tumors. In some cases, cells (0.1 ml) were injected in a PBS vehicle, and in other cases they were injected in a Matrigel suspension (Pretlow et al. 1991 ). In all cases, the cultured population of Clone H cells stained with X-gal to >90% of the cells, indicating the excellent stability of expression of the lacZ gene in this particular clone.

Tissue Isolation and Histochemical Staining
Primary tumors were isolated from sacrificed animals when they were generally >4 mm in their shortest dimension and <10 mm in their longest. In most cases, the entire primary tumor and the surrounding normal mouse tissues were isolated as a unit for X-gal staining. In select cases, the primary tumor was isolated, bisected with a scalpel, and then the halves fixed and X-gal-stained. Lungs and other organs were isolated intact from sacrificed animals as described previously ( Lin et al. 1990a , Lin et al. 1990b ; Kleinman et al. 1994 ). Fixation was performed at 4C for 1 hr with 2% (v/v) formaldehyde in PBS.

X-gal staining was executed on fixed tissues as described previously at pH 7.4 (overnight at room temperature) to minimize background tissue staining (Lin et al. 1990a , Lin et al. 1990b ; Lin and Culp 1992 ; Kleinman et al. 1994 ; Culp et al. 1998b ). X-gal staining was also performed on tissues from animals not injected with tumor cells to evaluate possible background staining of tissues. This was particularly important in bone, in which some background staining is observed in the growth regions at the ends of long bones of the animal. X-gal-stained primary tumors, overt metastases, and micrometastases were photographed on a Nikon SMZU Dissecting Microscope with Kodak 160T film.

Materials
Matrigel was obtained from Collaborative Research (Bedford, MA), X-gal from Research Organics (Cleveland, OH), G418 and RPMI 1640 medium from Gibco (Grand Island, NY), potassium ferricyanide, potassium ferrocyanide, and formaldehyde from Sigma Biochemicals (St Louis, MO), tissue culture plastic ware from Becton-Dickinson Labware (Oxnard, CA), and fetal calf serum and RPMI 1640 medium from Irvine Scientific (Santa Ana, CA).


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Primary Tumor Development
When LZ-CWR22R Clone B, D, or H was injected into the subcutis of nude mice in a PBS vehicle, there were differences in the tumorigenicity of the three clones. Clone B yielded tumors in all animals (Table 1). However, the vast majority of these tumors failed to give uniform X-gal stainability. For example, Fig 1A illustrates a tumor with only a minor fraction retaining expression of lacZ. In the case of Clone D, many animals yielded tumors when injected with >1 x 106 cells, but none of these tumors displayed any staining (not shown), consistent with the considerable instability of lacZ expression in cultured populations of Clone D. Because of this rapid loss of X-gal stainability by Clones B and D, they could not be studied any further to test for development of micrometastasis in various organs.



View larger version (89K):
[in this window]
[in a new window]
 
Figure 1. Primary tumors of lacZ transfectants. LZ-CWR22R Clone B or H cells (1 x 106) were injected into the subcutis of athymic nude mice. At the indicated times when the primary tumor had become large (>5 mm in the smallest dimension), animals were sacrificed and the region of the primary tumor excised from the surface of the animal. This region was then fixed and X-gal-stained as described in Materials and Methods. (A) Clone B primary tumor at 23 days post injection in a PBS vehicle. Most of this tumor does not stain for lacZ expression (large arrow), but a few small foci at the edge of the tumor do stain (e.g., small arrows). (B) Clone H primary tumor at 17 days post injection in a PBS vehicle. The entire primary tumor stains uniformly blue on X-gal staining. Original magnifications x 17. ( C) Clone H primary tumor at 44 days post injection in Matrigel. In this case, the primary tumor was bisected with a scalpel before fixation and X-gal staining. Note the uniform staining throughout the cut interface of the tumor. Blood vessels (e.g., white arrowheads) are evident throughout the interior of this large tumor. Original magnification x 13.

Figure 2. Micrometastasis to multiple target organs when Clone H cells were injected in a PBS vehicle. PBS-suspended Clone H cells were injected sc into nude mice. When the primary tumors had become large, the animals were sacrificed. Many internal organs were excised, fixed, and X-gal-stained to evaluate possible development of micrometastases. (A) A lung micrometastasis (small arrow) at 17 days post injection. Original magnification x 68. (B) A liver micrometastasis (small arrow) at 83 days post inection. Note the blood vessel adjacent to the micrometastasis (open arrow). Original magnification x 59. (C ) Micrometastases in the brain (e.g., small arrows) at 80 days post injection. Note the blood vessel proximal to these micrometastases (open arrow). Original magnification x 68.


 
View this table:
[in this window]
[in a new window]
 
Table 1. Tumorigenic competence of two independent lacZ transfectants of CWR22R cells a

Results for Clone H were very different. Only 15–40% of the animals injected with either 1 x 106 or 5 x 106 cells in a PBS vehicle developed tumors, even as long as 6 months post injection (Table 1). However, all these primary tumors in the subcutis were uniformly stainable with X-gal (Fig 1B), demonstrating the persistent expression of lacZ in this particular clone. Fig 1B shows a sizeable and highly stained primary tumor surrounded by fascia that is not X-gal-stainable. When any of these Clone H primary tumors were first sliced into halves with a scalpel and then fixed for X-gal staining, the uniformity of the stainability was again evident ( Fig 1C). This shows that non-expressing variants of the tumor cells do not arise at later time points of primary tumor development (e.g., at the most interior regions of the primary tumor). The extensive vasculature of the primary tumor is also evident at these later times [red-staining blood vessels against the intense blue background (Fig 1C)].

In contrast to the relatively low tumorigenicity of Clone H when injected in PBS, the same cells injected in Matrigel were 100% tumorigenic when 1–5 x 106 cells were used (Table 1). These Matrigel-borne primary tumors developed identically to PBS-borne tumors when pathological parameters were considered (not shown).

Micrometastasis to Multiple Organs of PBS-injected Cells
With PBS-injected Clone H cells, there was little evidence of overt metastases developing in most organs (except for liver; see below). However, lacZ stainability enables us to detect the very smallest of micrometastases. Micrometastases were observed in the lung for most mice with large tumors when PBS was used as the injection vehicle ( Table 2). An example of one lung micrometastasis is shown in Fig 2A. With lower frequency, micrometastases were observed in other organs as well (Table 2). Fig 2B shows a micrometastasis that has established itself reasonably close to a blood vessel in the liver. Fig 2C shows micrometastases close to a blood vessel in the brain. The relative distribution of micrometastases in animals bearing primary tumors and using PBS-injected cells was lung (>90%) >liver=bone (50%) >>kidney=brain.


 
View this table:
[in this window]
[in a new window]
 
Table 2. Tumor size and metastatic potential of Clone H cells a

Micrometastasis to Multiple Organs of Matrigel-injected Cells
When Matrigel was the vehicle, Clone H primary tumors yielded micrometastases in the lungs of all animals examined (Table 2). A lung micrometastasis is shown in Fig 3A, a liver micrometastasis in Fig 3B, and kidney micrometastases in Fig 3C. Micrometastasis frequency for all tumor-bearing animals was as follows: lung (100%) >bone (60%) >liver (20%) >>kidney or brain.



View larger version (95K):
[in this window]
[in a new window]
 
Figure 3. Micrometastasis when Clone H cells were injected in a Matrigel vehicle. Matrigel-suspended Clone H cells were injected sc into nude mice. When the primary tumors had become large, the animals were sacrificed. Many internal organs were excised, fixed, and X-gal-stained to evaluate development of micrometastases. (A) A lung micrometastasis (small arrow) at 44 days post injection. Original magnification x 102. ( B) Liver micrometastases (e.g., small arrows) at 72 days post injection. Original magnification x 34. (C) Kidney micrometastases (e.g., small arrows) at 44 days post injection. Original magnification x 17.

Figure 4. Micrometastasis to bone. Clone H cells were injected sc in either PBS or Matrigel vehicles. When primary tumors had become large, the animals were sacrificed for excision of many bones, followed by bone fixation and X-gal staining. (A) Micrometastases (small arrowheads) in the long bone of the leg 17 days post PBS injection. Original magnification x 42. (B) Micrometastases (e.g., small arrow) along the spinal column 113 days post PBS injection. Original magnification x 13. (C) Micrometastases (small arrows) along the spinal column 44 days post Matrigel injection. Original magnification x 34.

Several precautions were taken in these studies to guarantee that blue-staining foci truly contain tumor cells. First, a clonal population of CWR22Rv1 cells, shown to be tumorigenic in nude mice, was used for transfection of the lacZ gene. This obviates any possibility for another cell type from the original xenograft to be transfected with this gene. Second, a chromosome-integrating plasmid was used in these studies to obviate any episomal plasmid being expressed and possibly being transmitted to neighboring host tissue cells ( Culp et al. 1998a , Culp et al. 1998b ). Third, as shown by our laboratory for tumor cells (Lin and Culp 1992 ) and many other labs using transgenic animals ( Kruger et al. 1999 ), the polymerized blue product of X-gal digestion cannot be transmitted to neighboring host cells. Finally, the conditions used for fixation and X-gal staining of mouse tissues were developed to avoid any artifactual staining of tissue cell types ( Lin and Culp 1992 ; Culp et al. 1998a , Culp et al. 1998b ). By comparing X-gal staining of whole organs with serial sections of X-gal-stained foci, we previously determined that single tumor cells could be detected by our Nikon SMZU dissecting microscope. Therefore, these foci are truly micrometastases of prostate carcinoma cells.

Micrometastasis to Bone
Bone has been the most difficult and elusive target for PCA metastasis studies in animal model systems (Pretlow et al. 1994 ; Lalani et al. 1997 ; Wu et al. 1998 ; Yang et al. 1999 ). However, this is a very important aspect of the progression of the human disease. Therefore, lacZ stainability affords us maximal sensitivity for detecting micrometastases in the various bone systems of the nude mouse. Bone micrometastases were very evident with Matrigel-injected cells (Table 2). An example of micrometastases along the long bone of the animal is shown in Fig 4A for PBS-injected cells. In PBS-injected cells, micrometastases to spinal column were also occasionally observed ( Fig 4B). Fig 4C shows micrometastases along the spine after Matrigel injection.

Micrometastasis Outgrowth into Overt Metastases
The question arises of whether micrometastases in this LZ-CWR22R-H cell system can give rise to overt metastases. In none of the animals examined in this study were overt metastases ever observed in the lungs (not shown). This is a remarkable finding in light of the several hundred micrometastases that were scored in animals with very large primary tumors and in light of all animals that yielded lung micrometastases when primary tumors had developed. The same applied to bone micrometastases.

In contrast, overt metastases were observed in the livers of some animals. An example from a PBS-injected population is shown in Fig 5. Because micrometastases were much less common in the liver than in the lung and because comparable long time periods were involved, it is unlikely that insufficient time is the basis for poor outgrowth of overt metastases in the lung or bones. Apparently, there are environmental cues in the liver that permit effective outgrowth in the liver of Clone H cells, and these cues are missing in lung and in bone.



View larger version (71K):
[in this window]
[in a new window]
 
Figure 5. Overt metastasis in the liver. Clone H cells were injected sc in PBS. When primary tumors had become large (65 days post injection), animals were sacrificed for excision of many internal organs, followed by their fixation and X-gal staining. A large liver metastasis (large arow) was developing in the liver; it stained for lacZ expression throughout. Original magnification x 13.


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

These studies have identified a highly stable lacZ transfectant of a new human PCA cell line isolated from a primary tumor population, CWR22Rv1 (Sramkoski et al. 1999 ). This LZ-CWR22R-H cell line yields progression and metastatic competence that parallels the targets of the human disease, i.e., to lung, bone, and liver ( Pretlow et al. 1994 ; Lalani et al. 1997 ). This is an important finding because animal model systems of PCA have not been very successful in documenting metastasis to liver and bone unless already metastatic human PCA isolates were used as the starting material ( Wu et al. 1998 ; Yang et al. 1999 ). This progression pattern was evident without the need to introduce androgen into young nude mice, indicating the possible androgen-independence of these progression patterns.

Tumorigenesis of LZ-CWR22R-H cells was limited to 15–40% of animals injected when cells were injected sc in a PBS vehicle. However, all tumor-bearing animals yielded micrometastases in their lungs and in some cases in liver and bone, with brain and kidney micrometastases the most infrequent. The relative distribution of micrometastases with PBS-injected cells was lung (>90%) >liver=bone (50%) >>kidney= brain. The reasonably high level of progression of these cells into liver and bone offers optimism that this is a more accurate model of the human disease from an unselected primary tumor population of cells ( Pretlow et al. 1994 ; Lalani et al. 1997 ).

When Matrigel, a now commonly used vehicle for PCA cells ( Pretlow et al. 1991 ), was used as the injection vehicle for LZ-CWR22R-H cells, the pattern of tumor progression changed significantly. First, all animals that received bilateral injections developed primary tumors, many with tumors on both sides of the animal. Second, the pattern of metastasis changed quantitatively but not qualitatively. Micrometastasis frequency was as follows: lung (100%) >bone (60%) >liver (20%) >>kidney or brain. That progression to bone should be increased and that to liver decreased when Matrigel is used (compared to PBS injection) raises some interesting hypotheses that could be tested in future experiments. Matrigel may permit more facile selection and expansion of variants that are effective colonizers of bones. In contrast, there may be less effective expansion of variants that target the liver. Alternatively, Matrigel may permit many more cells to colonize the subcutis and thereby permit more rapid evolution of variants competent for migrating to bone structures. In any case, this system will be an effective model system for analyzing the molecular events that lead to evolution of bone and liver metastatic variants from a population of human PCA cells from a primary tumor of a human patient (Wainstein et al. 1994 ; Cheng et al. 1996 ).

A notable surprise in our analyses was the divergence in competence for forming overt metastases. With PBS- or Matrigel-injected cells, overt metastases were never observed in the lung or bone but were occasionally observed in the liver. That the liver received fewer tumor cells than either the lung or bones suggests that time or cell dosage was not a critical element in determining overt metastasis. Perhaps outgrowth in the lung and the bones is retarded by organ-specific environmental cues that are not present in the liver (Nicolson 1993 ; Radinsky 1995 ; Singh et al. 1997 ). It will be important to use orthotopic injection of LZ-CWR22R-H cells into the prostate gland to determine if these progression and overt metastasis patterns differ from those of subcutis-derived tumors ( Fu et al. 1992 ; Stephenson et al. 1992 ; Sato et al. 1997 ).

This study is not the first to use a marker gene to track PCA cells in an animal model system. Rubio et al. 1998 evaluated PC-3 cells tagged with luciferase to develop lymph node micrometastases after IM injection and by highly sensitive detection of fluorescence. They provided evidence that the lymphatic system was the preferred route of migration for these cells. Similarly, Yang et al. 1999 tagged PC-3 cells with green-fluorescent protein (GFP) and tracked micrometastasis to many bones of the animal by taking advantage of the ultrasensitive fluorescence of the GFP tag after sc or orthotopic injection. Both these studies used PC-3 cells derived from a bone metastasis from a human patient. However, use of a fluorescent tag (e.g., luciferase or GFP) obviates any evaluation of the tagged tumor cells with neighboring host tissue cells ( Chang and Chung 1989 ). Tumor cells tagged with histochemical marker genes can be readily evaluated at the single-cell level in any tissue in terms of their relationships with other cell types of the target organ, blood vessels, and other organ substructures ( Lin et al. 1990a , Lin et al. 1990b ; Lin et al. 1992 ; Kleinman et al. 1994 ; Culp et al. 1998a , Culp et al. 1998b ).

The lacZ-tagged CWR22R tumor cells described here provide a valuable system for evaluating gene regulation at the level of single tumor cells. The ability to identify X-gal-stained single tumor cells in any tissue, combined with laser-capture microdissection ( Emmert-Buck et al. 1996 ; Schutze and Lahr 1998 ; Simone et al. 1998 ) to target small groups of tumor cells, will enable us to test the levels of genes and their expression levels for possible relevance for metastatic progression of PCA. In addition, tagging of two genetically or phenotypically different CWR22R tumor derivatives with different histochemical marker genes (Lin et al. 1992 ) will provide a powerful paradigm, when combined with laser-capture microdissection, to evaluate the interrelationships of two different tumor subpopulations in different sites of the animal.


  Acknowledgments

Some of these studies were supported in part by the Comprehensive Cancer Center of the Ireland Cancer Center at Case Western Reserve University (NCI-supported via P30-CA43703) for pilot studies on PCA metastasis. More extensive support was provided by research grant DAMD17-98-1-8587 from the US Army on PCA metastasis.

Athymic nude mouse experiments were conducted in the Athymic Animal Facility (AAALAC-I-approved) of the Case Western Reserve University/Ireland Cancer Center and were approved by the Animal Care and Use Committee of this University. The assistance of Pamela Steele and Kathy Pustai of this facility is greatly appreciated. Special gratitude is extended to Drs Thomas and Theresa Pretlow, as well as Joseph Giaconia of their laboratory, for conveying their extensive knowledge of PCA xenograft biology to the authors during the execution of these studies. Special gratitude is extended to Dr James Jacobberger of the Ireland Cancer Center for the donation of tissue culture-adapted CWR22Rv1 PCA cells.

Received for publication September 29, 1999; accepted January 9, 2000.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Chang C-M , Chung LWK (1989 ) Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology 125:2719-2727 [Abstract]

Cheng L , Sun J , Pretlow TG , Culp J , Yang N-S (1996 ) CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy. J Natl Cancer Inst 88:607-611 [Abstract/Free Full Text]

Culp LA , Lin W-c , Kleinman NR , Campero NM , Miller CJ , Holleran JL (1998 ) Tumor progression, micrometastasis, and genetic instability tracked with histochemical marker genes. Prog Histochem Cytochem 33:329-350, a [Medline]

Culp LA , Lin W-c , Kleinman NR , O'Connor KL , Lechner R (1998 ) Earliest steps in primary tumor formation and micrometastasis resolved with histochemical markers of gene-tagged tumor cells. J Histochem Cytochem 46:557-567, b [Abstract/Free Full Text]

Emmert–Buck MR , Bonner RF , Smith PD , Chuaqui RF , Zhuang Z , Goldstein SR , Weiss RA , Liotta LA (1996 ) Laser capture microdissection. Science 274:998-1001 [Abstract/Free Full Text]

Fu X , Herrera H , Hoffman RM (1992 ) Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int J Cancer 52:987-990 [Medline]

Kleinman NR , Lewandowska K , Culp LA (1994 ) Tumour progression of human neuroblastoma cells tagged with a lacZ marker gene: earliest events at ectopic injection sites . Br J Cancer 69:670-679 [Medline]

Kruger A , Schirrmacher V , Khokha R (1999 ) The bacterial lacZ gene: an important tool for metastasis research and evaluation of new cancer therapies. Cancer Metast Rev 17:285-294

Lalani E-N , Lanaido ME , Abel PD (1997 ) Molecular and cellular biology of prostate cancer. Cancer Metast Rev 16:29-66 [Medline]

Lin W-c , Culp LA (1992 ) New insights into micrometastasis development using ultrasensitive marker genes. In Spandidos DA , ed. Current Perspectives on Molecular and Cellular Oncology. Vol 1. Part B. London , JAI Press, 261-309

Lin W-c , Pretlow TP , Pretlow TG , Culp LA (1990 ) Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res 50:2808-2817, a [Abstract]

Lin W-c , Pretlow TP , Pretlow TG , Culp LA (1990 ) Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells. J Natl Cancer Inst 82:1497-1503, b [Abstract]

Lin W-c , Pretlow TP , Pretlow TG , Culp LA (1992 ) High resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes . Am J Pathol 141:1331-1342 [Abstract]

Nagabhushan M , Miller CM , Pretlow TP , Giaconia JM , Edgehouse NL , Schwartz S , Kung H-J , de Vere White RW , Gumerlock PH , Resnick MI , Amini SB , Pretlow TG (1996 ) CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res 56:3042-3046 [Abstract]

Nicolson GL (1993 ) Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 204:171-180 [Medline]

Pretlow TG , Delmoro CM , Dilley GG , Spadafora CG , Pretlow TP (1991 ) Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res 51:3814-3817 [Abstract]

Pretlow TG , Pelley RJ , Pretlow TP (1994 ) Biochemistry of prostatic carcinoma. In Pretlow TG, II , Pretlow TP , eds. Biochemical and Molecular Aspects of Selected Cancers. Vol 2 . San Diego , Academic Press, 169-237

Pretlow TG , Wolman SR , Micale MA , Pelley RJ , Kursh ED , Resnick MI , Bodner DR , Jacobberger JW , Delmoro CM , Giaconia JM , Pretlow TP (1993 ) Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst 85:394-398 [Abstract]

Radinsky R (1995 ) Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metast Rev 14:323-338 [Medline]

Rubio N , Villacampa MM , Blanco J (1998 ) Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker. Lab Invest 78:1315-1325 [Medline]

Sato H , Gleave ME , Bruchovsky N , Rennie PS , Beraldi E , Sullivan LD (1997 ) A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res 57:1584-1589 [Abstract]

Schutze K , Lahr G (1998 ) Identification of expressed genes by laser-mediated manipulation of single cells. Nature Biotechnol 16:737-742 [Medline]

Simone NL , Bonner RF , Gillespie JW , Emmert–Buck MR , Liotta LA (1998 ) Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 14:272-276 [Medline]

Singh RK , Tsan R , Radinsky R (1997 ) Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis . Clin Exp Metast 15:140-150 [Medline]

Sramkoski RM , Pretlow TG , Giaconia JM , Pretlow TP , Schwartz S , Sy M-S , Marengo SR , Rhim JS , Zhang D , Jacobberger J (1999 ) A new human prostate carcinoma cell line, 22Rv1. In Vitro 35:403-409

Stephenson RA , Dinney CPN , Gohji K , Ordonez NG , Killion JJ , Fidler IJ (1992 ) Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 84:951-957 [Abstract]

Tan J-a , Sharief Y , Hamil KG , Gregory CW , Zang D-Y , Sar M , Gumerlock PH , deVere White RW , Pretlow TG , Harris SE , Wilson EM , Mohler JL , French FS (1997 ) Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol 11:450-459 [Abstract/Free Full Text]

van Steenbrugge GJ , van Weerden WM , de Ridder CMA , van der Kwast ThH , Schroder FH (1994 ) Development and application of prostatic xenograft models for the study of human prostate cancer. In Motta M , Serio M , eds. Sex Hormones and Antihormones in Endocrine Dependent Pathology : Basic and Clinical Aspects. Amsterdam , Elsevier Science, 11-22

van Weerden WM , de Ridder CMA , Verdaaskonk CL , Romijn JC , van der Kwast TH , Schroder FH , van Steenbrugge GJ (1996 ) Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 149:1055-1062 [Abstract]

Wainstein MA , He F , Robinson D , Kung H-J , Schwartz S , Giaconia JM , Edgehouse NL , Pretlow TP , Bodner DR , Kursh ED , Resnick MI , Seftel A , Pretlow TG (1994 ) CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res 54:6049-6052 [Abstract]

Wu TT , Sikes RA , Cui Q , Thalmann GN , Kao C , Murphy CF , Yang H , Zhau HE , Balian G , Chung LWK (1998 ) Establishing human prostate cancer cell xenografts in bone : induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77:887-894 [Medline]

Yang M , Jiang P , Sun F-X , Hasegawa S , Baranov E , Chishima T , Shimada H , Moossa AR , Hoffman RM (1999 ) A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res 59:781-786 [Abstract/Free Full Text]

Zhau H YE , Chang S-M , Chen B-Q , Wang Y , Zhang H , Kao C , Sang QA , Pathak SJ , Chung LWK (1996 ) Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 93:15152-15157[Abstract/Free Full Text]